Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PSMG3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PCCA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ADCY10P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF216 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR60 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APCDD1L-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHACTR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STRADA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
P2RY6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOSIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC654342 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MALSU1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RERE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DMWD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BICDL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on